Vitamin E-modified dialyzers

Contributions to Nephrology

Volumn 137, Issue , 2002, Pages 95-105

  Galli, Francesco ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT;

ARTERIOSCLEROSIS; DRUG EFFECT; HUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; RENAL REPLACEMENT THERAPY; REVIEW; VASCULAR ENDOTHELIUM;

ANTIOXIDANTS; ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; HUMANS; OXIDATIVE STRESS; RENAL DIALYSIS; VITAMIN E;

EID: 0036052398     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060235     Document Type: Article

References (48)

1. Galli F, Ronco C: Oxidant stress in hemodialysis. Nephron 2000;84:1-5.
2. Wratten ML, Tetta C, Ursini F, Sevanian A: Oxidant stress in hemodialysis: Prevention and treatment strategies. Kidney Int 2001;59(suppl 78):S32-S36.
3. Galli F, Canestrari F, Bellomo G: Physiopathology of the oxidative stress and its implication in uremia and dialysis. Contrib Nephrol. Basel, Karger, 1999, vol 127, pp 1-31.
4. Cristol JP, Canaud B, Rabesandratana H, Gaillard I, Serre A, Mion C: Enhancement of reactive oxygen species production and cell surface marker expression due to haemodialysis. Nephrol Dial Transplant 1994;9:389-394.
5. Markert M, Wauters JP: New aspects on oxidative metabolism of neutrophils during hemodialysis on different dialyzer membranes. Adv Exp Med Biol 1991;297:207-213.
6. Boaz M, Smetana S, Green MS: Secondary prevention with antioxidants of cardiovascular disease in end-stage renal disease (SPACE): Randomised placebo-controlled. Lancet 2000;356:1213-1218.
7. Wratten ML, Navino C, Tetta C, Verzetti G: Haemolipodialysis. Blood Purif 1999;17/2-3: 127-133.
8. Buocristiani U, Galli F, Benedetti S, Errico R, Beninati S, Ghibelli L, Rovidati S, Floridi A, Canestrari F: Quantitative and qualitative assessment and clinical meaning of molecules removed with BK membranes. Contrib Nephrol. Basel, Karger, 1998, vol 125, pp 133-158.
9. Galli F, Buoncristiani U, Floridi A, Ronco C: In vitro removal of oxidation and glycation-related toxins from uremic plasma by a new sorbent cartridge (abstract). 38th ERA-EDTA Congress, Vienna, 2001, p 217.
10. Galli F, Rovidati S, Chiarantini L, Kulurianu H, Canestrari F, Buoncristiani U: Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter. Kidney Int 1998;54:580-589.
11. Sasaki M, Hosoya N, Saruhashi M: Vitamin E modified cellulose membrane. Artif Organs 2000; 24:779-789.
12. Galli F, Floridi A, Buoncristiani U: Oxidant stress in hemodialysis patients. Contrib Nephrol. Basel, Karger, 2002, vol 137, pp 371-378.
13. Diplock AT, Chaleux J-L, Crozier-Willi G, Kok FS, Rice-Evans C, Roberfroid M, Stahl W, Wiña-Ribes J: Functional food sciences and defenses against reactive oxygen species. Br J Nutr 1998;80:S77-S112.
14. Galli F, Varga Z, Balla J, Ferraro B, Canestrari F, Floridi A, Kakuk G, Buoncristiani U: Vitamin E, lipid profile, and peroxidation in hemodialysis patients. Kidney Int 2001(suppl 78):S148-S154.
15. Weiss MF: Vitamin E for dialysis patients. Semin Dial 2001;14:71-72.
16. Hasselwander O, Young IS: Oxidative stress in chronic renal failure. Free Radic Res 1998;29:1-11.
17. Bonnefont-Rousselot D, Lehmann E, Jaudon MC, Delattre J, Perrone B, Rechke JP: Blood oxidative stress and lipoprotein oxidizability in haemodialysis patients: Effect of the use of a vitamin Ecoated dialysis membrane. Nephrol Dial Transplant 2000;15:2020-2028.
18. Usberti M, Bufano G, Lima G, Gazzotti RM, Tira P, Gerardi G, Di Lorenzo D: Increased red blood cell survival reduces the need of erythropoietin in hemodialyzed patients treated with exogenous glutathione and vitamin E-modified membrane. Contrib Nephrol. Basel, Karger, 1999, vol 127, pp 208-214.
19. Maccarrone M, Meloni C, Manca-di-Villahermosa S, Cococcetta N, Casciani CU, Finazzi-Agro A, Taccone-Gallucci M: Vitamin E suppresses 5-lipoxygenase-mediated oxidative stress in peripheral blood mononuclear cells of hemodialysis patients regardless of administration route. Am J Kidney Dis 2001;37:964-969.
20. Roob JM, Khoschsorur G, Tiran A, Horina JH, Holzer H, Winklhofer-Roob BM: Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis. J Am Soc Nephrol 2000;11:539-549.
21. Nemeth I, Turi S, Haszon I, Bereczki C: Vitamin E alleviates the oxidative stress of erythropoietin in uremic children on hemodialysis. Pediatr Nephrol 2000;14:13-17.
22. Clermont G, Lecour S, Cabanne J, Motte G, Guilland J, Chevet D, Rochette L: Vitamin Ecoated dialyzer reduces oxidative stress in hemodialysis patients. Free Radic Biol Med 2001;31:233-241.
23. Eiselt J, Racek J, Trefil L, Opatrny K Jr: Effects of a vitamin E-modified dialysis membrane and vitamin C infusion on oxidative stress in hemodialysis patients. Artif Organs 2001;25: 430-436.
24. Buoncristiani U, Galli F, Rovidati S, Albertini MC, Covarelli C, Canestrari F: Oxidative damage during hemodialysis using a vitamin E-modified dialysis membrane: A preliminary characterization. Nephron 1997;77:57-61.
25. Tarng DC, Huang TP, Liu TY, Chen HW, Sung YJ, Wei YH: Effect of vitamin E-bonded membrane on the 8-hydroxy 2′-deoxyguanosine level in leukocyte DNA of hemodialysis patients. Kidney Int 2000;58:790-799.
26. Mydlik M, Derzsiova K, Racz O, Sipulova A, Lovasova E, Petrovicova J: A modified dialyzer with vitamin E and antioxidant defense parameters. Kidney Int 2001(suppl 78):S144-S147.
27. Mune M, Yukawa S, Kishino M, Otani H, Kimura K, Nishikawa O, Takahashi T, Kodama N, Saika Y, Yamada Y: Effect of vitamin E on lipid metabolism and atherosclerosis in ESRD patients. Kidney Int 1999(suppl 71):S126-S129.
28. Gris J-C, Branger B, Vécina F, Al Sabadani B, Fourcade J, Schved J-F: Increased cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patients. Kidney Int 1994;46:807-813.
29. Miyazaki H, Matsuoka H, Itabe H, Usui M, Ueda S, Okuda S, Imaizumi T: Hemodialysis impairs endothelial function via oxidative stress: Effects of vitamin E-coated dialyzer. Circulation 2000; 101:1002-1006.
30. Keaney JF, Simon DI, Freedman JE: Vitamin E and vascular homeostasis: Implications for atherosclerosis. FASEB J 1999;13:965-976.
31. Bufano G, Usberti M, Mandolfo S, Testa S, Ferraro B, Galli F: Von Willebrand factor and autoantibodies against oxidized LDL in hemodialysis patients treated with vitamin E-modified dialysers. J Am Soc Nephrol 2001;12:355A.
32. Holvoet P, Donck J, Landeloos M, Brouwers E, Luijtens K, Arnout J, Lesaffre E, Vanrenterghem Y, Collen D: Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure. Thromb Haemost 1996;76:663-669.
33. Pertosa G, Grandaliano G, Gesualdo L, Ranieri E, Monno R, Schena FP: Interleukin-6, interleukin8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes. Kidney Int 1998;54:570-579.
34. Galli F, Rovidati S, Benedetti S, Canestrari F, Ferraro B, Floridi A, Buoncristiani U: Lipid peroxidation, leukocyte function and apoptosis in hemodialysis patients treated with vitamin Emodified filters. Contrib Nephrol. Basel, Karger, 1999, vol 127, pp 156-171.
35. Girndt M, Lengler S, Kaul H, Sester U, Sester M, Kohler H: Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction. Am J Kidney Dis 2000;35:95-104.
36. Tsuruoka S, Kawaguchi A, Nishiki K, Hayasaka T, Fukushima C, Sugimoto K, Saito T, Fujimura A: Vitamin E-bonded hemodialyzer improves neutrophil function and oxidative stress in patients with end-stage renal failure. Am J Kidney Dis 2002;39:127-133.
37. Shimazu T, Ominato M, Yasuda T, Sato T, Maeba T, Owada S, Ishida M: Effect of a vitamin E bonded dialysis membrane on neutrophil superoxide anion radical production. Kidney Int 2001; 59(suppl 78):137-143.
38. Omata M, Higuchi C, Demura R, Sanaka T, Nihei H: Reduction of neutrophil activation by vitamin E-modified dialyzer membranes. Nephron 2000;85:221-231.
39. Zaluska WT, Ksiazek A, Roliski J: Effect of vitamin E modified cellulose membrane on human lymphocyte, monocyte, and granulocyte CD11b/CD18 adhesion molecule expression during hemodialysis. ASAIO J 2001;47:619-622.
40. Dhondt A, Vanholder R, Glorieux G, Waterloos MA, De Smet R, Lesaffer G, Lameire N: Vitamin E-bonded cellulose membrane and hemodialysis bioincompatibility: Absence of an acute benefit on expression of leukocyte surface molecules. Am J Kidney Dis 2000;36:1140-1146.
41. Galli F, Canestrari F, Buoncristiani U: Biological effects of oxidative stress in hemodialysis: The possible roles of the vitamin E. Blood Purif 1999;17:79-94.
42. Jaber BL, Cendoroglo M, Balakrishnan VS, Perianayagam MC, King AJ, Pereira B: J. Apoptosis of leukocytes: Basic concepts and implications in uremia. Kidney Int 2001(suppl 78):S197-S205.
43. Satoh M, Yamasaki Y, Nagake Y, Kasahara J, Hashimoto M, Nakanishi N, Makino H: Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters. Kidney Int 2001; 59:1943-1950.
44. Pertosa G, Grandaliano G, Valente M, Montinaro V, Soccio M, Gesualdo L, Schena FP: In vivo evaluation of biocompatibility of a new dialyzer employing the vitamin E-modified cellulose membrane 'Excebrane E': Study of mechanisms involved in mononuclear cell activation. Contrib Nephrol. Basel, Karger, 1999, vol 127, pp 200-207.
45. Huraib S, Tanimu D, Shaheen F, Hejaili F, Giles C, Pagayon V: Effect of vitamin-E-modified dialysers on dialyser clotting, erythropoietin and heparin dosage: A comparative crossover study. Am J Nephrol 2000;20:364-368.
46. Usberti M, Bufano G, Lima G, Gazzotti RM, Tira P, Gerardi G, Di Lorenzo D: Increased red blood cell survival reduces the need of erythropoietin in hemodialyzed patients treated with exogenous glutathione and vitamin E-modified membrane. Contrib Nephrol. Basel, Karger, 1999, vol 127, pp 208-214.
47. Senior K: Antioxidants improve brain function in advanced renal failure. Lancet 2001;358:1075.
48. Ricciarelli R, Zingg JM, Azzi A: Vitamin E: Protective role of a Janus molecule. FASEB J 2001;15:2314-2325.